EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
about
Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study.Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementationDetection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl estersAssociation of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men.Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study.Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysisOmega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trialBaseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplementsRed blood cell fatty acid patterns and acute coronary syndrome.Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosSelective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorderLower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease.Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.Fish oil in primary and secondary cardiovascular preventionAssociations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acidsPredictors of omega-3 index in patients with acute myocardial infarction.Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?Cis-vaccenic acid and the Framingham risk score predict chronic kidney disease: the multi-ethnic study of atherosclerosis (MESA).Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea.Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarctionAn epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007Do omega-3 Fatty acids have a role in prevention of cardiovascular disease?The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease.Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteersRed blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarctionAcute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels.The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans.Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.Adult medication-free schizophrenic patients exhibit long-chain omega-3 Fatty Acid deficiency: implications for cardiovascular disease risk.Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.Erythrocyte stearidonic acid and other n-3 fatty acids and CHD in the Physicians' Health Study.Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative.Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study.Dietary fat in relation to erythrocyte fatty acid composition in menMembrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.Determinants of Blood Cell Omega-3 Fatty Acid ContentMyocardial infarction does not affect fatty-acid profiles in rats.Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial
P2860
Q27863412-512DD635-4783-4F6C-BBBE-D0553E02F9A3Q28066354-74166612-F6C9-4FED-A31E-3D3AC2F4109DQ28397031-2FF2F493-3394-4D9F-9B1D-BB98F6880440Q30435612-AF799952-C294-4DFD-BDC1-D92C268D9544Q30514016-D8A95AAE-199D-4B68-838C-38D5EB79D9B6Q30587127-A5AE5DD4-8D98-41B7-A06E-4F171968E4AEQ30876278-1DD321EE-D38B-4975-B0FD-53D52E229FEBQ31050854-1A9BD9C1-4C7B-45DC-A307-0DAE5476CE17Q33440563-E2BDC584-5831-4E9B-A060-2F5CACBD536DQ33666208-95051D8A-841D-47F1-9281-6A5CC663F001Q34065537-28B4F317-72E7-4A63-AC02-D9E94CF1ABE1Q34350376-44C88EE6-5626-4006-8B06-EEB29E05FF9AQ34681730-9BE4823A-9BE0-462B-83B3-B3B5E284CEF3Q34986662-E70C83AE-F281-4737-8880-7CC8DA667494Q35068782-1D5A6BB7-4CDA-4346-ABEE-0DCE1FD0F7D1Q35080572-7C608680-50F1-4699-A224-4E3857458F80Q35892876-68BFAA4C-86B4-4D60-8CFB-62BC8963EFB8Q35923284-F64FE038-DBC1-4650-B12C-4D57DB5BFB17Q35959620-CEB5919D-0ED8-4C2F-BA3D-8F5EA29626A2Q36081403-A450277A-9AFF-423C-84E2-640571FA8D7CQ36122324-272C2436-00D5-40C2-AA79-91512FE0B4C4Q36298031-FC4246BB-D2C0-4F92-9C40-EC09C0A848EAQ36495874-689FBA00-2A56-4D1E-8E3A-ED15E8315F30Q36520316-FB15521D-F9CC-492C-971B-06166C3867E5Q36616072-17B7BDBB-0620-41BF-995A-8CB715C89CECQ36630220-9C4432DC-AC7C-4D81-BB7D-A28F016100B2Q36659192-7900F892-78B0-45D0-B11B-B18DF7084E41Q36671100-47DE1B83-4F4B-4432-A483-7487218E88E2Q36692065-03D6BE9C-CB67-4AA2-BE5A-A0F6E5E37692Q36759325-AED14ECB-F4F6-4908-8BF8-067954211A6BQ36773267-AB74B55B-B815-43EC-922C-300CFA99E5F5Q36853173-7B3AF653-B823-4920-B560-D2F8CB07FCE4Q37000661-242555E1-BAD5-4B0B-9544-E96A03A8E28DQ37202910-2F058A71-613F-4AD1-9DBF-C1DBC947A9D5Q37236462-60C9A93A-1135-4673-8EA2-AF0FD4A87C87Q37298449-2C59E6C6-5742-497C-85CA-487A8935FB8CQ37414767-F9C94278-0827-46D6-9B74-A85624EC78DCQ37445796-AD327781-309B-450E-B0C5-F4A84BF79EB3Q37456415-F0FDCB2F-477F-4F19-B828-AA88CBEF4319Q37457616-608247AA-353B-4C0F-9398-EFAF72BC9F5A
P2860
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@ast
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@en
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@nl
type
label
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@ast
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@en
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@nl
prefLabel
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@ast
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@en
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@nl
P2093
P3181
P1433
P1476
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
@en
P2093
Kimberly J Reid
Robert C Block
Scott A Sands
William S Harris
P3181
P356
10.1016/J.ATHEROSCLEROSIS.2007.07.042
P407
P577
2008-04-01T00:00:00Z